Carteolol (ophthalmic) vs Sulfonylureas

Interacting Drugs
Carteolol (ophthalmic)
vs
Sulfonylureas
Security Level
Minor, Monitor Therapy
Mechanism
Sulfonylureas: Beta-Blockers may enhance the hypoglycemic effect of Sulfonylureas. Cardioselective beta-blockers (eg, acebutolol, atenolol, metoprolol, and penbutolol) may be safer than nonselective beta-blockers. All beta-blockers appear to mask tachycardia as an initial symptom of hypoglycemia. Ophthalmic beta-blockers are probably associated with lower risk than systemic agents.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Carteolol (ophthalmic) vs Sulfonylureas


Other Interactions of Carteolol (ophthalmic)

We are Developing Our database, More results coming soon.

Other Interactions of Sulfonylureas

We are Developing Our database, More results coming soon.